Cutler Group LP 23and Me Holding Co. Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$0.71 - $0.97 $77 - $105	-109 Reduced 30.97%	243 $0
Q3 2023 Nov 07, 2023	SELL	$0.96 - $2.01 $145 - $305	-152 Reduced 30.16%	352 $0
Q2 2023 Jul 18, 2023	SELL	$1.59 - $2.29 $796 - $1,147	-501 Reduced 49.85%	504 $0
Q1 2023 May 01, 2023	SELL	$2.05 - $2.87 $24,358 - $34,101	-11,882 Reduced 92.2%	1,005 $2,000
Q4 2022 Feb 07, 2023	SELL	$2.06 - $3.47 $4,208 - $7,089	-2,043 Reduced 13.68%	12,887 $27,000
Q3 2022 Oct 25, 2022	SELL	$2.6 - $5.12 $16,338 - $32,174	-6,284 Reduced 29.62%	14,930 $42,000
Q2 2022 Aug 04, 2022	BUY	$2.19 - $3.98 $1,968 - $3,578	899 Added 4.43%	21,214 $52,000
Q1 2022 Apr 14, 2022	BUY	$3.28 - $7.12 $49,439 - $107,319	15,073 Added 287.54%	20,315 $77,000
Q4 2021 Jan 18, 2022	BUY	$6.55 - $13.25 $29,095 - $58,856	4,442 Added 555.25%	5,242 $34,000
Q3 2021 Oct 26, 2021	SELL	$7.29 - $11.0 $201,036 - $303,347	-27,577 Reduced 97.18%	800 $7,000
Q2 2021 Jul 19, 2021	BUY	$9.87 - $13.32 $280,080 - $377,981	28,377 New	28,377 $331,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.